DEVLIN JODI (President, Therapeutics) sold 3.2% of their position (3.21K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market sale worth $13.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/20/2026ACC: 0001628280-26-020190
Officer· President, Therapeutics
Since Aug 2023
-3.21K
Net shares
Net seller
$13.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.21K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.16K
Price / share
$4.13
Trade value
$4.80K
% of position
1.2%
3/11/2026
100.57K→99.41K
Common Stock
Direct
Shares
−1.77K
Price / share
$4.09
Trade value
$7.25K
% of position
1.8%
3/12/2026
99.41K→97.64K
Common Stock
Direct
Shares
−273.00
Price / share
$4.12
Trade value
$1.12K
% of position
0.3%
3/16/2026
97.64K→97.36K
Total
Net shares
−3.21K
Net value
-$13.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −1.16K | $4.13 | $4.80K | 1.2% | 100.57K | 99.41K |
| Common Stock Direct | 3/12/2026 | S · Sale | −1.77K | $4.09 | $7.25K | 1.8% | 99.41K | 97.64K |
| Common Stock Direct | 3/16/2026 | S · Sale | −273.00 | $4.12 | $1.12K | 0.3% | 97.64K | 97.36K |
| Total | −3.21K | -$13.17K | ||||||
Derivative Transactions0
No derivative transactions reported